Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Bal Pharma has informed that it has submitted the business transacted at the 33rd Annual General Meeting of the Company conducted through audio visual means on 25.09.2020. The Meeting commenced at 11.00 AM and concluded at 11.50 PM.
The above information is a part of company’s filings submitted to BSE.